Tokyo-based investment giant Softbank wants to combine cells created from humans, which mimic brain cells, with traditional technology in an effort to create next generation artificial intelligence ...

The Ethical and Versatile Potential of Induced Pluripotent Stem Cells (iPSCs)Boston, Jan. 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Induced Pluripotent Stem Cells: ...

From April, the foundation will automatically make autologous iPS cells and turn them into, among others, heart muscle and nerve cells at a new facility in the city of Osaka. The iPS cell-derived ...

The versatility of induced pluripotent stem cells in regenerative medicine, disease modeling, drug discovery, and personalized therapy underpins their growing demand. Additionally, advancements in ...

A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by ...

Units will provide step-down accommodation for 34 inmates at Loughlan House, Shelton Abbey and Castlerea prisons ...

Gen Biomanufacturing InitiativesDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ...

Ips Heart Inc. has been awarded orphan drug designation by the FDA for its GIVI-MPC stem cell therapy for Becker muscular dystrophy. GIVI-MPC has the unique ability to create new muscle with full ...